Navigation Links
Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
Date:5/14/2008

MONTVALE, N.J., May 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today reported its financial results for the first quarter ended March 31, 2008.

"We had a productive start to 2008, reporting significant progress with our collaborations and refocusing our operations to advance four high-value programs," said Vaughn M. Kailian, President and Chief Executive Officer. "Roche's recent decision to license R3487/MEM 3454 highlights the potential of the compound, provides a development path forward for our lead nicotinic alpha-7 receptor agonist, strengthens our financial profile and certainly validates our expertise in CNS drug development. We remain on track to achieve the following 2008 goals for each of our four major development programs: completing and announcing top-line results for our Phase 2a trial of R3487/MEM 3454 in cognitive impairment in schizophrenia and our Phase 1 program for R4996/MEM 63908, initiating a Phase 2a trial for MEM 1414, and advancing our 5-HT6 antagonist program into the clinic."

Financial Results

For the quarter ended March 31, 2008, the Company reported a net loss of $13.4 million, or $0.18 per share, compared to a net loss of $8.9 million, or $0.13 per share, for the same period in 2007.

For the quarter ended March 31, 2008, the Company reported revenue of $0.8 million, compared to revenue of $2.7 million for the same period in 2007. The decrease in revenue is a result of the conclusion of the research and development funding portion of the Company's collaboration with Amgen related to the development of PDE10 inhibitors.

Research and development expenses for the quarter ended March 31, 2008 were $11.0 million compared to $9.9 million for the same p
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
2. Memory in artificial atoms
3. Memory Pharmaceuticals Receives Nasdaq Notification
4. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
5. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
6. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
7. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
9. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
10. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
11. ASU researchers improve memory devices using nanotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Last year, Formedix celebrated ... global provider of data management solutions for clinical trials. ... system for electronic data capture (EDC) and clinical data ... study execution tools added TrialMaster to its Transform for ... of Transform for TrialMaster, is being released this week, ...
(Date:7/23/2014)... 2014 DuPont Pioneer announced today that ... president of Agricultural Biotechnology (ABT), effective July 21, 2014. ... most recently as president, chief executive officer and board ... in the seed and crop protection industry to this ... Schickler , president of DuPont Pioneer. “I am looking ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... medicine transplant therapies are biological, but not magical. ... may seem to treat them as if they ... well as unsanctioned studies that constitute “stem cell ... as an approach to developing new regenerative medicine ...
Breaking Biology Technology:Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Sofinnova Raises $500 Million Biotech Venture Fund 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5
... Madison University of Wisconsin-Madison researcher Scott Sanders has ... one but a rainbow of colors, and to deliver the ... for scanning objects. , ,Researchers can derive information about a ... system allows them to try a full range of colors ...
... approaching and you're really feeling like a salary increase should ... have a great argument for your boss to get him ... dollars are tight and your boss is pre-disposed (or programmed ... ignore or discount most pay-me-more arguments. , ,So how can ...
... a new biomedical institute on Monday in Milwaukee. ... researchers and companies in southeastern Wisconsin is the goal ... is being established with a $1 million grant from ... Institute for Biomedical and Health Technologies is intended to ...
Cached Biology Technology:Want a raise? Ten best midwest tech salary-increase pitches 2Want a raise? Ten best midwest tech salary-increase pitches 3Want a raise? Ten best midwest tech salary-increase pitches 4Want a raise? Ten best midwest tech salary-increase pitches 5New biomedical institute aims to unite business and academia in SE Wisconsin 2New biomedical institute aims to unite business and academia in SE Wisconsin 3New biomedical institute aims to unite business and academia in SE Wisconsin 4
(Date:7/23/2014)... study of identical twins has found that early reading ... in the journal Child Development , was conducted ... College London. , "Since reading is an ability that ... instruction," according to Stuart J. Ritchie, research fellow in ... study. "Early remediation of reading problems might aid not ...
(Date:7/23/2014)... North Carolina State University shows that urban "heat islands" ... States. One factor is that researchers have found warmer ... gloomy scale insect a significant tree pest ... times more adult gloomy scales on urban trees. , ... the gloomy scale in cities, and now we know ...
(Date:7/23/2014)... tissue samples cultured from cystic fibrosis patients, scientists at ... Lung Institute have shown that a new CF drug ... drug. , The finding, published today in the journal ... CFTR protein becomes unstable and loses its ability to ... drugs. The research offers several insights into how novel ...
Breaking Biology News(10 mins):Stronger early reading skills predict higher intelligence later 2Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4
... 25, 2012Warner C. Greene, MD, PhDwho directs virology ... the 2012 Alumni Achievement Award from the Washington ... This prestigious award acknowledges outstanding personal achievement ... the Washington University Medical Center. Dr. Greene trained ...
... MEDIA ALERT , "Basic science and clinical medicine ... however aim at improving strategies to manage cancer patients. We ... and efficiently implement them in the clinic." Sherene ... 2012 will focus on four major areas: , ...
... Barbara, Calif.) An international team of researchers has ... happens in virtually every cell of our bodies. ... chains of amino acids assume their specific shapes, hence ... In the human body, proteins fold to become muscles, ...
Cached Biology News:Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award 2Fourth IMPAKT Breast Cancer Conference 2Fourth IMPAKT Breast Cancer Conference 3In protein folding, internal friction may play a more significant role than previously thought 2